2nd Circ. Says Coercion Key To Namenda Injunction Ruling
The Second Circuit explained Thursday that Actavis PLC's plan to force Alzheimer's patients using its Namenda dementia drug to switch to a newer version by pulling the older formulation from the...To view the full article, register now.
Already a subscriber? Click here to view full article